Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Shares Issued
Ratios

enVVeno Medical (NVNO) Accumulated Depreciation & Amortization (2017 - 2020)

enVVeno Medical has reported Accumulated Depreciation & Amortization over the past 4 years, most recently at $464359.0 for Q3 2020.

  • Quarterly results put Accumulated Depreciation & Amortization at $464359.0 for Q3 2020, up 24.19% from a year ago — trailing twelve months through Sep 2020 was $464359.0 (up 24.19% YoY), and the annual figure for FY2019 was $393107.0, up 1414.51%.
  • Accumulated Depreciation & Amortization for Q3 2020 was $464359.0 at enVVeno Medical, up from $438068.0 in the prior quarter.
  • Over the last five years, Accumulated Depreciation & Amortization for NVNO hit a ceiling of $464359.0 in Q3 2020 and a floor of $25956.0 in Q4 2018.
  • Median Accumulated Depreciation & Amortization over the past 4 years was $373919.0 (2019), compared with a mean of $352836.3.
  • Biggest five-year swings in Accumulated Depreciation & Amortization: crashed 92.85% in 2018 and later soared 1414.51% in 2019.
  • enVVeno Medical's Accumulated Depreciation & Amortization stood at $362936.0 in 2017, then crashed by 92.85% to $25956.0 in 2018, then soared by 1414.51% to $393107.0 in 2019, then rose by 18.13% to $464359.0 in 2020.
  • The last three reported values for Accumulated Depreciation & Amortization were $464359.0 (Q3 2020), $438068.0 (Q2 2020), and $408788.0 (Q1 2020) per Business Quant data.